Abstract

BackgroundEndovascular or intra-arterial treatment (IAT) increases the likelihood of recanalization in patients with acute ischemic stroke caused by a proximal intracranial arterial occlusion. However, a beneficial effect of IAT on functional recovery in patients with acute ischemic stroke remains unproven. The aim of this study is to assess the effect of IAT on functional outcome in patients with acute ischemic stroke. Additionally, we aim to assess the safety of IAT, and the effect on recanalization of different mechanical treatment modalities.Methods/designA multicenter randomized clinical trial with blinded outcome assessment. The active comparison is IAT versus no IAT. IAT may consist of intra-arterial thrombolysis with alteplase or urokinase, mechanical treatment or both. Mechanical treatment refers to retraction, aspiration, sonolysis, or use of a retrievable stent (stent-retriever). Patients with a relevant intracranial proximal arterial occlusion of the anterior circulation, who can be treated within 6 hours after stroke onset, are eligible. Treatment effect will be estimated with ordinal logistic regression (shift analysis); 500 patients will be included in the trial for a power of 80% to detect a shift leading to a decrease in dependency in 10% of treated patients. The primary outcome is the score on the modified Rankin scale at 90 days. Secondary outcomes are the National Institutes of Health stroke scale score at 24 hours, vessel patency at 24 hours, infarct size on day 5, and the occurrence of major bleeding during the first 5 days.DiscussionIf IAT leads to a 10% absolute reduction in poor outcome after stroke, careful implementation of the intervention could save approximately 1% of all new stroke cases from death or disability annually.Trial registrationNTR1804 (7 May 2009)/ISRCTN10888758 (24 July 2012).Electronic supplementary materialThe online version of this article (doi:10.1186/1745-6215-15-343) contains supplementary material, which is available to authorized users.

Highlights

  • Endovascular or intra-arterial treatment (IAT) increases the likelihood of recanalization in patients with acute ischemic stroke caused by a proximal intracranial arterial occlusion

  • If IAT leads to a 10% absolute reduction in poor outcome after stroke, careful implementation of the intervention could save approximately 1% of all new stroke cases from death or disability annually

  • Intravenous thrombolysis Treatment with intravenous (IV) alteplase, aiming at early reperfusion, has been proven effective for patients with acute ischemic stroke when they are treated within 4.5 hours after stroke onset

Read more

Summary

Introduction

Endovascular or intra-arterial treatment (IAT) increases the likelihood of recanalization in patients with acute ischemic stroke caused by a proximal intracranial arterial occlusion. A beneficial effect of IAT on functional recovery in patients with acute ischemic stroke remains unproven. The aim of this study is to assess the effect of IAT on functional outcome in patients with acute ischemic stroke. We aim to assess the safety of IAT, and the effect on recanalization of different mechanical treatment modalities. Intra-arterial treatment Delivery of the thrombolytic agent at the site of the occlusion may improve the likelihood of recanalization, reperfusion of still viable tissue and, recovery of neurological deficits. Several randomized clinical trials of intra-arterial treatment (IAT) for acute ischemic stroke have been conducted and published [8,9,10]. In the Middle cerebral artery Embolism Local fibrinolytic intervention Trial, mechanical treatment was allowed [10], but this was not available in Prolyse in Acute Cerebral Thromboembolism (PROACT) I or PROACT II [8,9]

Objectives
Methods
Findings
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call